Abstract:Background: Inadequate accuracy of ultrasound-guided core needle biopsy (US-CNB) urges further improvement for the diagnosis and management of lymphoma to meet with the practitioners' increased reliance on this mini-invasive approach.Methods: Data related to US-CNB of the deep-sited dominant lesions suspicious of lymphoma detected by computer tomography or positron-emission tomography/computer tomography for eligibility assessment of three prospective clinical trials were collected in advance. A retrospective analysis of the prospective data collection was performed, in which Viable-targeting US-CNB that Color Doppler flow imaging (CDFI) and/or contrast enhanced ultrasound (CEUS) were employed to select viable area for biopsy target compared with Routine US-CNB that routine procedure of evaluation and guidance using gray-scale ultrasound with CDFI in terms of the yield of clinically actionable diagnosis and safety, and determinants for the successful US-CNB that established an actionable diagnosis were explored. The establishment of final diagnosis was based on surgical pathology or medical response to therapy with follow-up at least 6 months.Results: A total of 245 patients underwent Routine US-CNB (N = 120) or Viable-targeting US-CNB (N = 125), of which 91 (91/120, 75.8%) and 112 (112/125, 89.6%) were revealed with actionable diagnoses, respectively (p = 0.004, OR 0.846, 95% CI: 0.753–0.952). And 239 patients established final diagnoses. Diagnostic yields of actionable diagnosis according to the final diagnoses were 78.4% (91/116) and 91.1% (112/123) (p = 0.006, OR 0.554, 95% CI: 0.333–0.920), 82.6% (90/109) and 92.5% (111/120) for malignancy, 84.0% (84/100) and 91.8% (101/110) for lymphoma, 85.1% (80/94) and 92.3% (96/104) for Non-Hodgkin Lymphoma, 66.7% (4/6) and 83.3% (5/6) for Hodgkin Lymphoma in Routine and Viable-targeting CNB groups, respectively. No major complications were observed. Dominant lesions with actionable diagnosis in US-CNB were with higher FDG-avid Standardized Uptake Value. Binomial logistic regression revealed that actionable diagnosis of US-CNB was correlated with group and ancillary studies.Conclusion: Viable-Targeting US-CNB was superior to routine US-CNB in term of the yield of actionable diagnosis for deep-sited dominant lesions suspicious of lymphoma, which demonstrated a potential to be the initial approach in this setting.

CLINIC APPLICATION OF CORE NEEDLE BIOPSY OF CERVICAL LYMPHADENOPATHY GUIDED BY COLOR ULTRASOUND

Application of Pathological Diagnosis by Using Ultrasound-Guided Percutaneous Biopsy for Cervical Lymph Lesions

Efficacy of ultrasound-guided core needle biopsy in cervical lymphadenopathy: A retrospective study of 6,695 cases

Clinic Value of Ultrasound-Guided Needle Biopsy for the Diagnosis of Thyroid Nodule Lesions

Clinical Value of Ultrasound-Guided Percutaneous Biopsy of Breast Lesions

The application of contrast enhanced ultrasound for core needle biopsy of subpleural pulmonary lesions: retrospective analysis in 92 patients

Diagnostic Value of Coarse Needle Biopsy in Retroperitoneal Solid Mass Guided by Color Ultrasound

Application of Ultrasound-Guided Fine Needle Aspiration and Core Needle Biopsy in Diagnosis of Thyroid Nodules

The Clinical Value of Color Doppler Ultrasound-Guided Core Needle Biopsy in Diagnosing Maxillofacial Neck Mass

The Value of Udtrasound-Guided Core Needle Biopsy in Neoadjuvant Chemotherapy of Breast Cancer

Significance of Ultrasound-Guided Core Needle Biopsy in Diagnosis of Thyroid Nodules

Ultrasound-guided core needle biopsies for workup of lymphadenopathy and lymphoma

Ultrasound-guided core needle biopsy in the diagnosis of breast lesions]

Diagnostic Value of Ultrasound-Guided Core Needle Biopsy for Soft Tissue Tumors

Diagnostic value of ultrasound-guided 14 gauge-core needle biopsy in breast nodules

Application of color Doppler ultrasound guided core needle biopsy in diagnosis of salivary gland masses

Value of core needle biopsy in the diagnosis of breast neoplasms:A report of 1394 cases

Evaluation of supplementary diagnostic value of contrast-enhanced ultrasound for lymph node puncture biopsy

Feasibility, efficacy, and safety of core needle biopsy as a first-line method for cervical lymphadenopathy

Core Needle Biopsy Targeting the Viable Area of Deep-Sited Dominant Lesion Verified by Color Doppler and/or Contrast-Enhanced Ultrasound Contribute to the Actionable Diagnosis of the Patients Suspicious of Lymphoma

Application of core needle biopsy in the diagnosis of breast mass